Elevated C‐Reactive Protein–Albumin–Lymphocyte Index Is Associated With Reduced Mortality in Chronic Inflammatory Airway Diseases: A Population‐Based Observational Study
Mediators of Inflammation · 2026
DOI: 10.1155/mi/8257027 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Mediators of Inflammation, 2026. Verfasst von Yuting Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, North Sichuan Medical College, Nanchong 637000, Sichuan, China, nsmc.edu.cn. Hauptthemen laut MEDLINE: C-Reactive Protein, Lymphocytes, Serum Albumin, Inflammation. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zigong Science and Technology Program of China.
Abstract (Originalsprache)
Background
The C‐reactive protein–albumin–lymphocyte (CALLY) index, a novel composite marker derived from lymphocyte count, serum albumin, and C‐reactive protein (CRP) levels, is commonly used to assess nutritional and inflammatory status. However, existing studies have not clarified the association between the CALLY index and prognosis in patients with chronic inflammatory airway diseases (CIADs). This study aims to elucidate the relationship between the CALLY index and the risks of all‐cause and cardiovascular mortality among CIAD patients in the United States.
Methods
This investigation included 4128 patients with CIAD from the National Health and Nutrition Examination Survey (NHANES, 1999–2010). The CALLY index was measured only at baseline. We employed weighted Cox proportional hazards regression models to assess the association between the CALLY index and risks of all‐cause and cardiovascular mortality across three progressively adjusted models. To evaluate potential nonlinear dose–response relationships, we applied restricted cubic spline (RCS) models. Additionally, subgroup analyses and sensitivity analyses were conducted to verify the robustness of our findings.
Results
Multivariable‐adjusted Model 3 demonstrated that, compared with the lowest quartile, the highest CALLY index quartile showed a significant inverse association with both all‐cause and cardiovascular mortality, with corresponding HRs of 0.36 (95% CI: 0.27–0.47) and 0.33 (95% CI: 0.21–0.51), respectively (both p < 0.05).
Conclusions
The CALLY index showed a significant inverse association with all‐cause and cardiovascular mortality among U.S. adults with CIAD, suggesting its potential value as a prognostic tool for risk stratification in this group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, North Sichuan Medical College, Nanchong 637000, Sichuan, China, nsmc.edu.cn.
- Department of Respiratory and Critical Care Medicine, Zigong First People's Hospital, Zigong 643000, Sichuan, China.
- Department of Clinical Laboratory, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510000, Guangdong, China, gzhmc.edu.cn.
ORCID-Profile: Yuting Fan, Zhao Chen, Mingshan Xue, Wenqiang Li, Youli Wen, Baoqing Sun, Zhiping Deng
Förderung
- Zigong Science and Technology Program of China
Zitieren
APA
Fan, Y., Chen, Z., Xue, M., Li, W., Wen, Y., Sun, B., & Deng, Z. (2026). Elevated C‐Reactive Protein–Albumin–Lymphocyte Index Is Associated With Reduced Mortality in Chronic Inflammatory Airway Diseases: A Population‐Based Observational Study. Mediators of Inflammation. https://doi.org/10.1155/mi/8257027
Vancouver
Fan Y, Chen Z, Xue M, Li W, Wen Y, Sun B, et al. Elevated C‐Reactive Protein–Albumin–Lymphocyte Index Is Associated With Reduced Mortality in Chronic Inflammatory Airway Diseases: A Population‐Based Observational Study. Mediators of Inflammation. 2026. doi:10.1155/mi/8257027
BibTeX
@article{Fan2026,
author = {Fan, Yuting and Chen, Zhao and Xue, Mingshan and Li, Wenqiang and Wen, Youli and Sun, Baoqing and Deng, Zhiping},
title = {Elevated C‐Reactive Protein–Albumin–Lymphocyte Index Is Associated With Reduced Mortality in Chronic Inflammatory Airway Diseases: A Population‐Based Observational Study},
journal = {Mediators of Inflammation},
year = {2026},
doi = {10.1155/mi/8257027}
}
EUVIMED